reports
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree...
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story Busy is getting candid about navigating her ADHD diagnosis and treatment experience with Qelbree®The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two years (2020-2022)1Although symptoms are present in childhood, a significant portion of women with ADHD don’t receive a diagnosis until they are adults2 ROCKVILLE, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mother of two, Busy Philipps is teaming up with Supernus Pharmaceuticals ...
SPS Commerce Reports First Quarter 2024 Financial Results
SPS Commerce Reports First Quarter 2024 Financial Results Company delivers 93rd consecutive quarter of topline growth Revenue and recurring revenue growth of 19% year-over-year MINNEAPOLIS, April 25, 2024 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced financial results for the first quarter ended March 31, 2024. Financial Highlights First Quarter 2024 Financial Highlights Revenue was $149.6 million in the first quarter of 2024, compared to $125.9 million in the first quarter of 2023, reflecting 19% gro...
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Resu...
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it expects to report financial and business results for the first quarter of 2024 after the market closes on Wednesday, May 8, 2024. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a ...
Diodes Incorporated to Announce First Quarter 2024 Financial Results o...
PLANO, Texas--(BUSINESS WIRE)-- Diodes Incorporated (Nasdaq: DIOD) will host a conference call on Thursday, May 9, 2024, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss its first quarter 2024 financial results. Joining Gary Yu, President of Diodes Incorporated, will be Brett Whitmire, Chief Financial Officer; and Emily Yang, Senior Vice President of Worldwide Sales and Marketing. The Company intends to distribute the announcement of its first quarter 2024 financial results on that same day at 3:05 p.m. Central Time (4:05 p.m. Eastern Time). Analysts and investors are invited ...
SPS Commerce Announces Date of First Quarter 2024 Financial Results
SPS Commerce Announces Date of First Quarter 2024 Financial Results MINNEAPOLIS, April 11, 2024 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail cloud services, today announced that it will issue its financial results for the first quarter ended March 31, 2024, after the market close on Thursday, April 25, 2024. SPS Commerce will host a call to discuss the results at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on the same day. To access the call, please dial 1-833-816-1382, or outside the U.S. 1-412-317-0475 at least 15 minutes prior to the 3:30 p.m. CT start...
- Wedbush Research
FL FOOT LOCKER INC.
FATE FATE THERAPEUTICS INC
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
AAPL APPLE INC.
NKE NIKE INC. CLASS B
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
IGMS IGM BIOSCIENCES
RVMD REVOLUTION MEDICINES
ORIC ORIC PHARMACEUTICALS
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
TNGX TANGO THERAPEUTICS
IKNA INC
TSVT IKENA ONCOLOGY INC
GLUE 2SEVENTY BIO INC
NUVL MONTE ROSA THERAPEUTICS INC
NUVALENT INC
- Matt Quigley
- Tom Nikic
Supernus Provides Regulatory Update for SPN-830
Supernus Provides Regulatory Update for SPN-830 ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced a regulatory update for SPN-830. SPN-830 is an investigational apomorphine infusion device for the continuous treatment of motor fluctuations (“off” episodes) in Parkinson’s disease (PD) under U.S. Food and Drug Administration (FDA) review. The FDA has issued a Complete Response Letter (CRL) ...
- Wedbush Research
ADS ADIDAS AG
BLUE BLUEBIRD BIO INC.
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
ORCL ORACLE CORPORATION
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NCMI NATIONAL CINEMEDIA INC.
MU MICRON TECHNOLOGY INC.
LEN LENNAR CORPORATION CLASS A
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FL FOOT LOCKER INC.
FB FACEBOOK INC. CLASS A
CNK CINEMARK HOLDINGS INC.
AXTI AXT INC.
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
UAA UNDER ARMOUR INC. CLASS A
ALPN ALPINE IMMUNE SCIENCES
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
NKE NIKE INC. CLASS B
MSFT MICROSOFT CORPORATION
LEGH LEGACY HOUSING CORP
DDOG DATADOG INC CLASS A
SMCI SUPER MICRO COMPUTER
PHVS INC.
SNOW PHARVARIS NV
ONON SNOWFLAKE INC. CLASS A
STX ON HOLDING AG
GFS SEAGATE TECHNOLOGY HLDGS PLC
GLOBALFOUNDRIES INC
- Matt Quigley
- Tom Nikic
- Valens Research
CNC - Valens Credit Report - 2024 03 13
Cash bond markets are overstating CNC's credit risk with a YTW of 5.617% relative to an Intrinsic YTW of 4.827%, while CDS markets are slightly overstating credit risk with a CDS of 126bps relative to an Intrinsic CDS of 69bps. Furthermore, Moody's is overstating CNC's fundamental credit risk with its Ba1 credit rating three notches below Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As positives, most management members ar...
- Wedbush Research
TRIP TRIPADVISOR INC.
MELI MERCADOLIBRE INC.
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FL FOOT LOCKER INC.
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
DKS DICK'S SPORTING GOODS INC.
DECK DECKERS OUTDOOR CORPORATION
DRI DARDEN RESTAURANTS INC.
SE SEA ADS
AMZN AMAZON.COM INC.
BKNG BOOKING HOLDINGS INC.
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
RMBL RUMBLEON INC
PGY PAGAYA TECHNOLOGIES LTD
GETY GETTY IMAGES HOLDINGS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
CART MAPLEBEAR INC.
- Matt Quigley
- Tom Nikic
- Valens Research
Valens Equity Weekly Insights - 2024 03 12
Centene (CNC) is the largest managed health care provider for Medicaid and one of the top providers for Medicare as well with over 26 million members across all of its services. Uniform Accounting highlights that the market is overly pessimistic given exaggerated fears surrounding government spending, suggesting the potential for equity upside. Centene is one of the largest managed care organizations (“MCO”) in the United States. The company provides healthcare services to nearly one in 15...
Fabrinet: 1 director
A director at Fabrinet sold 10,000 shares at 222.168USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
- Wedbush Research
WBS WEBSTER FINANCIAL CORPORATION
VRNS VARONIS SYSTEMS INC.
VLY VALLEY NATIONAL BANCORP
QLYS QUALYS INC.
PANW PALO ALTO NETWORKS INC.
NYCB NEW YORK COMMUNITY BANCORP INC.
LEN LENNAR CORPORATION CLASS A
FL FOOT LOCKER INC.
DKS DICK'S SPORTING GOODS INC.
CRM SALESFORCE.COM INC.
CFG CITIZENS FINANCIAL GROUP INC.
BKU BANKUNITED INC.
OKTA OKTA INC. CLASS A
MDB MONGODB INC. CLASS A
MSFT MICROSOFT CORPORATION
ZS ZSCALER INC.
TENB TENABLE HOLDINGS
AX AXOS FINANCIAL INC.
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
ASO ACADEMY SPORTS AND OUTDOORS
PLTR PALANTIR TECHNOLOGIES
SBTX SILVERBACK THERAPEUTICS
MLTX MOONLAKE IMMUNOTHERAPEUTICS
- Matthew McCartney
- Nathan Friedman
- Seth Basham
CECO Environmental Corp: 2 directors
Two Directors at CECO Environmental Corp bought 52,500 shares at between 19.784USD and 19.865USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.